While a vaccine will represent a significant turning point in the fight against COVID-19, there will still be a long way to go.
Blog
Mass General is part of a multicenter research effort to overcome key challenges in the long term preservation and reuse of organs, cells, tissues and more.
CAR T cell therapy is a promising form of treatment for cancer, and now Ragon Institute investigator Todd Allen, PhD, recently published findings suggesting dual CAR T cell therapy could be an option for HIV.
Recent research from Ragon Institute researcher Xu Yu, MD, finds that HIV elite controllers can prevent the virus from replicating by sequestering the viral genome in gene deserts.
In a guest blog post, Mass General and Ragon Institute researcher Shiv Pillai, MD, PhD, explains his research examining why COVID-19 immunity may be challenging: The virus could be causing immune system amnesia.
Certain questions and theories about face mask safety and efficacy continue to circulate, which can make it hard to tell the difference between fact and fiction. To set the record straight, we spoke with George Alba, MD, a researcher and pulmonary and critical care specialist at Massachusetts General Hospital.
Widespread testing and tracing are crucial to managing the spread of COVID-19, but there are several different kinds of tests that each have a specific use. Learn more about which test may be best for you.
Severity in chest x-rays increase the likelihood of admission to the intensive care unit, intubation and death.
Mass General investigators who are co-affiliated with the Broad Institute discuss patient care and the hospital’s response to COVID-19.
The Ragon Institute of MGH, MIT and Harvard is a leading institution in infectious disease and immunology research, here are five things to know.